23.79 USD
+0.16 (+0.68%)
23.79 USD
0 (0%)
Overall PRVA gets a fundamental rating of 4 out of 10. We evaluated PRVA against 100 industry peers in the Health Care Providers & Services industry. PRVA has a great financial health rating, but its profitability evaluates not so good. PRVA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PRVA had positive earnings in the past year.
PRVA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
PRVA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PRVA has a Return On Assets (1.34%) which is in line with its industry peers.
The Return On Equity of PRVA (2.56%) is comparable to the rest of the industry.
PRVA has a Return On Invested Capital of 2.45%. This is comparable to the rest of the industry: PRVA outperforms 48.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PRVA (0.89%) is comparable to the rest of the industry.
PRVA's Profit Margin has declined in the last couple of years.
PRVA's Operating Margin of 1.38% is in line compared to the rest of the industry. PRVA outperforms 46.00% of its industry peers.
In the last couple of years the Operating Margin of PRVA has declined.
Looking at the Gross Margin, with a value of 10.17%, PRVA is doing worse than 75.00% of the companies in the same industry.
PRVA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
PRVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PRVA has more shares outstanding
PRVA has more shares outstanding than it did 5 years ago.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PRVA has an Altman-Z score of 4.47. This indicates that PRVA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.47, PRVA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.47 |
ROIC/WACC0.28
WACC8.78%
2.3 Liquidity
A Current Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
The Current ratio of PRVA (1.67) is better than 63.00% of its industry peers.
A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.67, PRVA is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.00% over the past year.
Measured over the past 5 years, PRVA shows a small growth in Earnings Per Share. The EPS has been growing by 7.43% on average per year.
Looking at the last year, PRVA shows a quite strong growth in Revenue. The Revenue has grown by 19.01% in the last year.
PRVA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.17% yearly.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
3.2 Future
The Earnings Per Share is expected to grow by 69.59% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.73% on average over the next years.
EPS Next Y23.86%
EPS Next 2Y71.26%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue Next Year19.33%
Revenue Next 2Y14.38%
Revenue Next 3Y13.26%
Revenue Next 5Y2.73%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 183.00, which means the current valuation is very expensive for PRVA.
Compared to the rest of the industry, the Price/Earnings ratio of PRVA is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.34, PRVA is valued quite expensively.
Based on the Price/Forward Earnings ratio of 73.74, the valuation of PRVA can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as PRVA.
PRVA is valuated expensively when we compare the Price/Forward Earnings ratio to 23.56, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 183 | ||
| Fwd PE | 73.74 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PRVA is valued a bit more expensive than the industry average as 62.00% of the companies are valued more cheaply.
PRVA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.43 | ||
| EV/EBITDA | 66.11 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRVA does not grow enough to justify the current Price/Earnings ratio.
PRVA's earnings are expected to grow with 69.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.67
PEG (5Y)24.62
EPS Next 2Y71.26%
EPS Next 3Y69.59%
5. Dividend
5.1 Amount
PRVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.79
+0.16 (+0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.69%
Inst Owner Change2.16%
Ins Owners1.85%
Ins Owner Change0.2%
Market Cap2.93B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.44
Price Target32.03 (34.64%)
Short Float %2.81%
Short Ratio3.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)-0.49%
PT rev (3m)3.29%
EPS NQ rev (1m)-37.27%
EPS NQ rev (3m)-40.31%
EPS NY rev (1m)-19.57%
EPS NY rev (3m)-17.44%
Revenue NQ rev (1m)2.3%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)3.28%
Revenue NY rev (3m)3.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 183 | ||
| Fwd PE | 73.74 | ||
| P/S | 1.43 | ||
| P/FCF | 26.43 | ||
| P/OCF | 26.43 | ||
| P/B | 4.13 | ||
| P/tB | 7.92 | ||
| EV/EBITDA | 66.11 |
EPS(TTM)0.13
EY0.55%
EPS(NY)0.32
Fwd EY1.36%
FCF(TTM)0.9
FCFY3.78%
OCF(TTM)0.9
OCFY3.78%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)7.67
PEG (5Y)24.62
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.47 |
F-Score7
WACC8.78%
ROIC/WACC0.28
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y23.86%
EPS Next 2Y71.26%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year19.33%
Revenue Next 2Y14.38%
Revenue Next 3Y13.26%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.2%
EBIT Next 3Y111.25%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
What is the valuation status for PRVA stock?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
What is the valuation of PRIVIA HEALTH GROUP INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 183 and the Price/Book (PB) ratio is 4.13.
What is the earnings growth outlook for PRIVIA HEALTH GROUP INC?
The Earnings per Share (EPS) of PRIVIA HEALTH GROUP INC (PRVA) is expected to grow by 23.86% in the next year.